Prosecution Insights
Last updated: May 29, 2026

Oregon Health & Science University

11 pending office actions • 10 art units • 11 examiners • 0 of 11 (0%) have an AI response strategy ready • 16 patents granted in the last 365 days

Portfolio Summary

11
Total Pending OAs
5
Non-Final OAs
5
Final Rejections
1
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 11 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

7
Overdue
0
Due this week
2
Due this month
1
Due in next 60 days
1
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 11 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (7)Due ≤ 30 days (2)Due ≤ 60 days (1)Due later (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

1
Hard (9%)
7
Medium (64%)
1
Easy (9%)
2
Unknown (18%)

Rejection Statute Mix

BucketCases
§101 only1 (9%)
§103 only7 (64%)
§112 only1 (9%)
No statute on record2 (18%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

7
Life Sciences
64% of docket
1
Information Tech
9% of docket
2
Communications
18% of docket
0
Semiconductors
0% of docket
1
Mechanical / Eng
9% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

110 h
Manual time on pending OAs
22 h
Time saved (low, 20%)
38 h
Time saved (mid, 35%)
1.0 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
RAPILLO, KRISTINE K 1 28.5% +27.2%
PECKHAM, RICHARD GRANT 1 68.3% +35.6%
THIRUGNANAM, GANDHI 1 73.9% +11.7%
JOHANNSEN, DIANA B 1 53.2% +41.1%
YANG, WEI WEN 1 82.3% +10.9%
MEJIAS, SAMANTHA LEE 1 47.4% +62.5%
BUNKER, AMY M 1 29.2% +46.5%
ROGERS, JAMES WILLIAM 1 46.3% +21.8%
PETERS, ALEC JON 1 68.6% +61.7%
BERHANE, SELAM 1 61.3% +55.5%

Quick Wins (1)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18129649 SYSTEMS AND METHODS FOR GENERATING BIOMARKER ACTIVATION MAPS YANG, WEI WEN 9d overdue

Hard Cases (3)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.

App #TitleExaminerDue in
18316719 ASSAYS AND METHODS FOR SELECTING A TREATMENT REGIMEN FOR A SUBJECT WITH LEUKEMIA JOHANNSEN, DIANA B 134d overdue
18074790 SINGLE CELL WHOLE GENOME LIBRARIES AND COMBINATORIAL INDEXING METHODS OF MAKING THEREOF BUNKER, AMY M 4d overdue
18858236 MACHINE-LEARNING-BASED MEAL DETECTION AND SIZE ESTIMATION USING CONTINUOUS GLUCOSE MONITORING (CGM) AND INSULIN DATA RAPILLO, KRISTINE K 27d

Interview Candidates (10)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18316719 ASSAYS AND METHODS FOR SELECTING A TREATMENT REGIMEN FOR A SUBJECT WITH LEUKEMIA JOHANNSEN, DIANA B 134d overdue
17786186 MULTI-SPECIFIC T CELL RECEPTORS PETERS, ALEC JON 73d overdue
17790698 OXAZINE-BASED WATER-SOLUBLE FLUOROPHORE COMPOUNDS FOR IN VIVO NERVE IMAGING ROGERS, JAMES WILLIAM 50d overdue
18129649 SYSTEMS AND METHODS FOR GENERATING BIOMARKER ACTIVATION MAPS YANG, WEI WEN 9d overdue
18074790 SINGLE CELL WHOLE GENOME LIBRARIES AND COMBINATORIAL INDEXING METHODS OF MAKING THEREOF BUNKER, AMY M 4d overdue
17616941 TUMOR-ASSOCIATED ANTIGEN-SPECIFIC T CELL RESPONSES BERHANE, SELAM 4d overdue
18407998 USE OF SOBETIROME AND PRODRUGS AND DERIVATIVES THEREOF FOR TREATING PITT-HOPKINS SYNDROME PECKHAM, RICHARD GRANT 2d overdue
18858236 MACHINE-LEARNING-BASED MEAL DETECTION AND SIZE ESTIMATION USING CONTINUOUS GLUCOSE MONITORING (CGM) AND INSULIN DATA RAPILLO, KRISTINE K 27d

Top Art Units

Art UnitApps
1618 2
3682 1
1627 1
2672 1
1682 1
2662 1
1684 1
1641 1
1675 1
2186 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18858236 MACHINE-LEARNING-BASED MEAL DETECTION AND SIZE ESTIMATION USING CONTINUOUS GLUCOSE MONITORING (CGM) AND INSULIN DATA RAPILLO, KRISTINE K 3682 §103 Final Rejection 27d Pending Oct 18, 2024
18407998 USE OF SOBETIROME AND PRODRUGS AND DERIVATIVES THEREOF FOR TREATING PITT-HOPKINS SYNDROME PECKHAM, RICHARD GRANT 1627 Other Non-Final OA 2d overdue Pending Jan 09, 2024
18455154 SIGNAL ATTENUATION-COMPENSATED AND PROJECTION RESOLVED OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY (SACPR-OCTA) THIRUGNANAM, GANDHI 2672 §103 Final Rejection 63d Pending Aug 24, 2023
18316719 ASSAYS AND METHODS FOR SELECTING A TREATMENT REGIMEN FOR A SUBJECT WITH LEUKEMIA JOHANNSEN, DIANA B 1682 §101 Non-Final OA 134d overdue Pending May 12, 2023
18129649 SYSTEMS AND METHODS FOR GENERATING BIOMARKER ACTIVATION MAPS YANG, WEI WEN 2662 §103 Non-Final OA 9d overdue Pending Mar 31, 2023
18044444 STABILIZED HYDROPHOBIC NANOPARTICLES FOR ULTRASOUND IMAGING MEJIAS, SAMANTHA LEE 1618 §103 Non-Final OA 42d Pending Mar 08, 2023
18074790 SINGLE CELL WHOLE GENOME LIBRARIES AND COMBINATORIAL INDEXING METHODS OF MAKING THEREOF BUNKER, AMY M 1684 §112 Final Rejection 4d overdue Pending Dec 05, 2022
17790698 OXAZINE-BASED WATER-SOLUBLE FLUOROPHORE COMPOUNDS FOR IN VIVO NERVE IMAGING ROGERS, JAMES WILLIAM 1618 §103 Final Rejection 50d overdue Pending Jul 01, 2022
17786186 MULTI-SPECIFIC T CELL RECEPTORS PETERS, ALEC JON 1641 Other Non-Final OA 73d overdue Pending Jun 16, 2022
17616941 TUMOR-ASSOCIATED ANTIGEN-SPECIFIC T CELL RESPONSES BERHANE, SELAM 1675 §103 Final Rejection 4d overdue Pending Dec 06, 2021
17114433 PREDICTING AND PREVENTING HYPOGLYCEMIA IN PATIENTS HAVING TYPE 1 DIABETES DURING PERIODS OF INCOGNIZANCE USING BIG DATA ANALYTICS AND DECISION THEORETIC ANALYSIS GIRI, PURSOTTAM 2186 §103 Non-Final OA 14d Pending Dec 07, 2020

Managing Oregon Health & Science University's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month